Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1617, 2007-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Liraglutide leads over the long-term for T2DM in 6 countries
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. :
Access to resources
Recommend
Repeat oral insulin may be beneficial in T2DM
Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. :
Drugs, lifestyle changes potentially cost saving in type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 467, 2004-01 ,pp. :
Current and Future Treatment Directions in T2DM
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :
Pioglitazone improves measures of T2DM and dyslipidaemia
Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. :